Clinical Manifestations due to a Point Mutation of the Mitochondrial tRNAleu(UUR) Gene in Five Families with Diabetes Mellitus

Internal Medicine

Volumn 37, Issue 3, 1998, Pages 265-272

  Shigemoto, Michika ^a   Yoshimasa, Yasunao ^a   Yamamoto, Yuji ^a   Hayashi, Tatsuya ^a   Suga, Junko ^a   Inoue, Gen ^a   Okamoto, Motozumi ^a   Jingami, Hisato ^a   Tsuda, Kinsuke ^a   Yamamoto, Toshikazu ^b   Yagura, Toshihiro ^b   Oishi, Mariko ^c   Tsujii, Satoshi ^c   Kuzuya, Hideshi ^c   Nakao, Kazuwa ^a  

^a KYOTO UNIVERSITY   (Japan)

^b TENRI HOSPITAL   (Japan)

^c NATIONAL HOSPITAL ORGANIZATION KYOTO MEDICAL CENTER   (Japan)

Author keywords

Diabetes mellitus; Hypoparathyroidism; Insulin secretion; Maternal inheritance; Mitochondrial DNA

Indexed keywords

INSULIN; MITOCHONDRIAL RNA; ORAL ANTIDIABETIC AGENT; TRANSFER RNA;

ADOLESCENT; ADULT; AGED; AMINO ACID SUBSTITUTION; ARTICLE; BODY MASS; DIABETIC NEPHROPATHY; DISEASE SEVERITY; EXTRACHROMOSOMAL INHERITANCE; FEMALE; GENETIC SUSCEPTIBILITY; HUMAN; HYPOPARATHYROIDISM; INSULIN RELEASE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PEDIGREE ANALYSIS; POINT MUTATION; PROTEINURIA;

ADOLESCENT; ADULT; AGED; BLOOD GLUCOSE; DIABETES COMPLICATIONS; DIABETES MELLITUS; DNA PRIMERS; DNA, MITOCHONDRIAL; FEMALE; GENOTYPE; GLUCOSE CLAMP TECHNIQUE; HUMANS; HYPOPARATHYROIDISM; INSULIN; MALE; MIDDLE AGED; PARATHYROID HORMONE; PEDIGREE; POINT MUTATION; POLYMERASE CHAIN REACTION; RNA, TRANSFER, LEU;

EID: 0031840512     PISSN: 09182918     EISSN: None     Source Type: Journal    
DOI: 10.2169/internalmedicine.37.265     Document Type: Article

References (33)

1. DeFronzo RA. Lilly lecture 1987. The triumvirate: beta-cell, muscle, liver. A collusion responsible for NIDDM. Diabetes 37: 667, 1988.
2. Steiner DF, Tager HS, Chan SJ, Nanjo K, Sanke T, Rubenstein AH. Lessons learned from molecular biology of insulin-gene mutations. Diabetes Care 13: 600, 1990.
3. Taylor SI, Cama A, Accili D, et al. Genetic basis of endocrine disease. 1. Molecular genetics of insulin resistant diabetes mellitus. J Clin Endocrinol Metab 73: 1158, 1991.
4. Froguel P, Zouali H, Vionnet N, et al. Familial hyperglycemia due to mutations in glucokinase. Definition of a subtype of diabetes mellitus. N Engl J Med 328: 697, 1993 (see comments).
5. Ballinger SW, Shoffner JM, Hedaya EV, et al. Maternally transmitted diabetes and deafness associated with a 10.4 kb mitochondrial DNA deletion. Nat Genet 1: 11, 1992.
6. leu(UUR) gene in a large pedigree with maternally transmitted type II diabetes mellitus and deafness. Nat Genet 1: 368, 1992.
7. Sener A, Malaisse WJ. Stimulation by D-glucose of mitochondrial oxidative events in islet cells. Biochem J 246: 89, 1987.
8. Kadowaki H, Tobe K, Mori Y, et al. Mitochondrial gene mutation and insulin-deficient type of diabetes mellitus. Lancet 341: 893, 1993 (letter).
9. Ciafaloni E, Ricci E, Shanske S, et al. MELAS: clinical features, biochemistry, and molecular genetics. Ann Neurol 31: 391, 1992.
10. leu(UUR) gene associated with the MELAS subgroup of mitochondrial encephalo-myopathies. Nature 348: 651, 1990 (see comments).
11. Ciulla TA, Sklar RM, Hauser SL. A simple method for DNA purification from peripheral blood. Anal Biochem 174: 485, 1988.
12. leu(UUR) gene in mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes (MELAS). Am J Hum Genet 49: 590, 1991.
13. DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 237: E214, 1979.
14. Reardon W, Ross RJ, Sweeney MG, et al. Diabetes mellitus associated with a pathogenic point mutation in mitochondrial DNA. Lancet 340: 1376, 1992 (see comments).
15. leu(UUR) gene. FEBS Lett 321: 194, 1993.
16. leu(UUR) gene mutation in Japanese patients. Diabetologia 37: 504, 1994.
17. Kadowaki T, Kadowaki H, Mori Y, et al. A subtype of diabetes mellitus associated with a mutation of mitochondrial DNA. N Engl J Med 330: 962, 1994.
18. Alcolado JC, Majid A, Brockington M, et al. Mitochondrial gene detects in patients with NIDDM. Diabetologia 37: 372, 1994.
19. leu(UUR) gene. Diabetes 43: 746, 1994.
20. leu(UUR). Lancet 338: 143, 1991.
21. leu(UUR) mutation. Neurology 43: 1015, 1993.
22. leu(UUR) mutation in mitochondrial encephalomyopathy, lactic acidosis, and strokelike episodes (MELAS): genetic, biochemical, and morphological correlations in skeletal muscle. Am J Hum Genet 50: 934, 1992.
23. leu(UUR) mutation associated with mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes. Mol Cell Biol 12: 480, 1992.
24. Chomyn A, Martinuzzi A, Yoneda M, et al. MELAS mutation in mtDNA binding site for transcription termination factor causes defects in protein synthesis and in respiration but no change in levels of upstream and downstream mature transcripts. Proc Natl Acad Sci USA 89: 4221, 1992.
25. Murayama Y, Kawai K, Watanabe Y, Yoshikawa H, Yamashita K, Insulin and glucagon secretion are suppressed equally during both hyper-and euglycemia by moderate hyperinsulinemia in patients with diabetes mellitus. J Clin Endocrinol Metab 68: 925, 1989.
26. leu(UUR) mutation in the mitochondrial DNA of a patient with MELAS syndrome. Neurology 41: 1663, 1991.
27. Zeviani M, Gellera C, Pannacci M, et al. Tissue distribution and transmission of mitochondrial DNA deletions in mitochondrial myopathies. Ann Neurol 28: 94, 1990.
28. Goto Y, Itami N, Kajii N, Tochimaru H, Endo M, Horai S. Renal tubular involvement mimicking Bartter syndrome in a patient with Kearns-Sayre syndrome. J Pediatr 116: 904, 1990.
29. Zeviani M, Nonaka I, Bonilla E, et al. Fatal infantile mitochondrial myopathy and renal dysfunction caused by cytochrome c oxidase deficiency: immunological studies in a new patient. Ann Neurol 17: 414, 1985.
30. Van Biervliet JP, Bruinvis L, Ketting D, De Bree PK, Van der Heiden C, Wadman SK. Hereditary mitochondrial myopathy with lactic acidemia, a De Toni-Fanconi-Debre syndrome, and a defective respiratory chain in voluntary striated muscles. Pediatr Res 11: 1088, 1977.
31. Morten KJ, Cooper JM, Brown GK, Lake BD, Pike D, Poulton J. A new point mutation associated with mitochondrial encephalomyopathy. Hum Mol Genet 2: 2081, 1993.
32. Zupanc ML, Moraes CT, Shanske S, Langman CB, Ciafaloni E, DiMauro S. Deletion of mitochondrial DNA in patients with combined features of Kearns-Sayre and MELAS syndromes. Ann Neurol 29: 680, 1991.
33. Hess JF, Parisi MA, Bennett JL, Clayton DA. Impairment of mitochondrial transcription termination by a point mutation associated with the MELAS subgroup of mitochondrial encephalomyopathies. Nature 351: 236, 1991.